Condition: Autoimmune Diseases · Sponsor: AlphaNa Bioscience Company Limited
This is an investigator-initiated trial designed to evaluate the safety, tolerability and primary efficacy of AFN50 injection for the treatment of autoimmune diseases.
This description comes directly from the study's public registry record.
Beicheng SUN, Dr · +86 551 6292 2800 · sunbc0207@163.com
Huan ZHOU, Dr · +8613665527160 · zhouhuanbest@vip.163.com
Always discuss trial participation with your own doctor first.
| First Affiliated Hospital of Anhui Medical University | Hefei, Anhui, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07408336